— Know what they know.
Not Investment Advice

BGLC NASDAQ

BioNexus Gene Lab Corp.
1W: -17.2% 1M: -34.8% 3M: -37.8% YTD: -65.7% 1Y: -72.5% 3Y: -97.7%
$1.35
-0.02 (-1.46%)
 
Weekly Expected Move ±9.1%
$1 $1 $2 $2 $2
NASDAQ · Industrials · Industrial - Distribution · Alpha Radar Strong Sell · Power 30 · $2.7M mcap · 1M float · 7.68% daily turnover · Short 31% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.7M
52W Range1.07-8.98
Volume9,198
Avg Volume99,514
Beta2.21
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOSu-Leng Tan
Employees19
SectorIndustrials
IndustryIndustrial - Distribution
IPO Date2021-01-08
Tower B, Vertical Business Suite
Kuala Lumpur, WP 59200
MY
60 1 2212 6512
About BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.

Recent Insider Trades

NameTypeSharesPriceDate
Wong Yee Meng 0 2023-07-19
Yap Chee Keong 0 2023-07-19
Yew Chak Hua 0 2023-07-19
Lin Chai Ping 0 2023-07-19
Teoh Boon Teong 0 2023-07-19

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms